Patents by Inventor Emily Rana CORSE

Emily Rana CORSE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL ADMINISTRATION ROUTES FOR IMMUNE AGONISTS
    Publication number: 20200188296
    Abstract: Disclosed herein is a new use of liquid pharmaceutical preparations comprising immune agonistic antibodies, resulting in improved tolerability/adverse event profile while at least maintaining the same level of biological activity of said immune agonist.
    Type: Application
    Filed: November 27, 2019
    Publication date: June 18, 2020
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Gonzalo Acuña, Emily Rana Corse, Jehad Charo, Martin Lechmann, Martin Stern
  • COMBINATION THERAPY OF ANTIBODIES ACTIVATING HUMAN CD40 AND ANTIBODIES AGAINST HUMAN PD-L1
    Publication number: 20200095313
    Abstract: The present invention relates to a pharmaceutical product for the treatment of a proliferative disease, comprising the combination of an antibody, or an antigen-binding portion thereof, that specifically binds to human CD40; and a PD-L1 antibody; and optionally a 3rd component which comprises as an active ingredient a cytokine inhibitor.
    Type: Application
    Filed: December 11, 2019
    Publication date: March 26, 2020
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Emily Rana CORSE, Olivier FREYTAG, Christian GERDES, Marine LE CLECH, Hyam LEVITSKY, Marion OTT, Martin STERN, Wei XU
  • COMBINATION THERAPY OF ANTIBODIES ACTIVATING HUMAN CD40 AND ANTIBODIES AGAINST HUMAN PD-L1
    Publication number: 20180051077
    Abstract: The present invention relates to a pharmaceutical product for the treatment of a proliferative disease, comprising the combination of an antibody, or an antigen-binding portion thereof, that specifically binds to human CD40; and a PD-L1 antibody; and optionally a 3rd component which comprises as an active ingredient a cytokine inhibitor.
    Type: Application
    Filed: October 2, 2017
    Publication date: February 22, 2018
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Emily Rana Corse, Olivier Freytag, Christian Gerdes, Marine Le Clech, Hyam Levitsky, Marion OTT, Martin Stern, Wei Xu
  • COMBINATION THERAPY OF ANTIBODIES ACTIVATING HUMAN CD40 AND ANTIBODIES AGAINST HUMAN PD-L1
    Publication number: 20160045597
    Abstract: The present invention relates to a pharmaceutical product for the treatment of a proliferative disease, comprising the combination of an antibody, or an antigen-binding portion thereof, that specifically binds to human CD40; and a PD-L1 antibody; and optionally a 3rd component which comprises as an active ingredient a cytokine inhibitor.
    Type: Application
    Filed: August 14, 2015
    Publication date: February 18, 2016
    Applicant: HOFFMANN-LA ROCHE INC.
    Inventors: Emily Rana CORSE, Olivier FREYTAG, Christian GERDES, Marine LE CLECH, Hyam LEVITSKY, Marion OTT, Martin STERN, Wei XU